clomipramine has been researched along with apomorphine in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (38.89) | 18.7374 |
| 1990's | 3 (16.67) | 18.2507 |
| 2000's | 3 (16.67) | 29.6817 |
| 2010's | 5 (27.78) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Biziere, K; Bouchet, MJ; Bourguignon, JJ; Kan, JP; Maghioros, G; Moire, C; Schlewer, G; Wermuth, CG; Worms, P | 1 |
| Johans, C; Kinnunen, PK; Söderlund, T; Suomalainen, P | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Milson, JA; Pycock, CJ | 1 |
| Delini-Stula, A; Vassout, A | 1 |
| Kourkoubas, A; Pitoulis, S; Spyraki, C | 1 |
| Kourkoubas, A; Papadopoulou, Z; Spyraki, C; Varonos, D | 1 |
| Andreas, K; Engert, U; Fischer, HD | 1 |
| Argiolas, A; Fadda, F; Gessa, GL; Serra, G | 1 |
| Bastide, P; Coudert, P; Rubat, C; Tronche, P | 1 |
| Allison, K; Baker, GB; Greenshaw, AJ; Paetsch, PR | 1 |
| Buchanan, JT; Hosford, DM; Kemnitz, CP; Strauss, TR | 1 |
| Bonilla-Jaime, H; Brianza-Padilla, M; Hernández-González, M; Jiménez-Tlapa, M; Molina-Jiménez, T; Zepeda, RC | 1 |
1 review(s) available for clomipramine and apomorphine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
17 other study(ies) available for clomipramine and apomorphine
| Article | Year |
|---|---|
3-aminopyridazine derivatives with atypical antidepressant, serotonergic, and dopaminergic activities.
Topics: Animals; Antidepressive Agents; Chemical Phenomena; Chemistry; Dopamine Agents; Female; Mice; Pyridazines; Receptors, Dopamine; Receptors, Serotonin; Structure-Activity Relationship | 1989 |
Surface activity profiling of drugs applied to the prediction of blood-brain barrier permeability.
Topics: Blood-Brain Barrier; Lipid Bilayers; Micelles; Permeability; Pharmaceutical Preparations; Structure-Activity Relationship; Surface Properties | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Effects of drugs acting on cerebral 5-hydroxytryptamine mechanisms on dopamine-dependent turning behaviour in mice.
Topics: Amphetamines; Animals; Apomorphine; Behavior; Clomipramine; Cyproheptadine; Diet; Dopamine; Fenclonine; Humans; Lysergic Acid Diethylamide; Male; Methysergide; Mice; Mice, Inbred Strains; Serotonin; Stereotyped Behavior; Tryptophan | 1976 |
Modulation of dopamine-mediated behavioural responses by antidepressants: effects of single and repeated treatment.
Topics: Amitriptyline; Animals; Antidepressive Agents; Apomorphine; Behavior, Animal; Clomipramine; Dopamine; Humans; Hydroxydopamines; Imipramine; Male; Maprotiline; Rats; Rats, Inbred Strains; Stereotyped Behavior; Time Factors | 1979 |
Chronic antidepressant treatment increases the apomorphine-induced elevation of plasma corticosterone in rats.
Topics: Animals; Antidepressive Agents; Apomorphine; Clomipramine; Corticosterone; Electroshock; Male; Radioimmunoassay; Rats; Rats, Inbred Strains | 1988 |
Chlorimipramine, electroconvulsive shock and combination thereof: differential effects of chronic treatment on apomorphine-induced behaviours and on striatal and mesocortical dopamine turnover.
Topics: Animals; Apomorphine; Cerebral Cortex; Clomipramine; Corpus Striatum; Dopamine; Electroshock; Grooming; Humans; Male; Motor Activity; Rats; Rats, Inbred Strains; Stereotyped Behavior | 1985 |
[Effect of psychodrugs on morphine effectivity (author's transl)].
Topics: Analgesia; Animals; Apomorphine; Clomipramine; Haloperidol; Male; Mice; Morphine; Time Factors | 1980 |
Hyposensitivity of dopamine "autoreceptors" induced by chronic administration of tricyclic antidepressants.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Antidepressive Agents, Tricyclic; Apomorphine; Caudate Nucleus; Clomipramine; Corpus Striatum; Dopamine; Imipramine; Male; Motor Activity; Rats; Receptors, Dopamine | 1980 |
Behavioural profile of two potential antidepressant pyridazine derivatives including arylpiperazinyl moieties in their structure, in mice.
Topics: 5-Hydroxytryptophan; Analgesia; Animals; Antidepressive Agents; Apomorphine; Behavior, Animal; Blepharoptosis; Citalopram; Clomipramine; Drug Interactions; Fluoxetine; Hypothermia; Imipramine; Injections, Intraperitoneal; Injections, Subcutaneous; Male; Mice; Models, Molecular; Motor Activity; Naloxone; Piperazines; Pyridazines; Reserpine; Structure-Activity Relationship; Swimming; Trazodone; Yohimbine | 1995 |
Chronic antidepressant drug treatment attenuates motor-suppressant effects of apomorphine without changing [3H]GBR 12935 binding.
Topics: Animals; Antidepressive Agents; Apomorphine; Brain Chemistry; Clomipramine; Desipramine; Male; Monoamine Oxidase; Motor Activity; Phenelzine; Piperazines; Rats; Rats, Sprague-Dawley; Receptors, Dopamine; Stereotyped Behavior | 1993 |
Modulation of swimming in the lamprey, Petromyzon marinus, by serotonergic and dopaminergic drugs.
Topics: 5-Hydroxytryptophan; Animals; Apomorphine; Clomipramine; Dopamine Agents; Dopamine Agonists; Image Processing, Computer-Assisted; Lampreys; Motor Activity; Selective Serotonin Reuptake Inhibitors; Serotonin Agents; Swimming | 1995 |
The neonatal treatment with clomipramine decreases sexual motivation and increases estrogen receptors expression in the septum of male rats: Effects of the apomorphine.
Topics: Animals; Animals, Newborn; Apomorphine; Clomipramine; Copulation; Dopamine Agonists; Estrogen Receptor alpha; Estrogen Receptor beta; Female; Male; Motivation; Nucleus Accumbens; Rats; Rats, Wistar; Reward; RNA, Messenger; Selective Serotonin Reuptake Inhibitors; Septum of Brain; Signal Transduction | 2019 |